- When a person's belongings are increasingly lost and he or she forgets the agreed appointments or the constantly used pin codes, it is worth applying for research, urges Professor of Neurology Juha Rinne.

In an interview with Pentti Huovinen's Direct Speech on Health, he talks about memory disorders, the most common of which in Finland is Alzheimer's disease.

The incidence of the disease increases with age.

About 3% of people aged 65-75 have a memory condition.

In the age group older than 10 years, the percentage is 17 and in the over 85 age group it is already about 30.

- The cost of memory illness is 2 billion euros a year in Finland, Rinne says.

The incidence of the disease increases with age.Image: AlfaTV

The professor goes through the causes of the disease and current treatments.

Again, we are reminded of good diet, exercise and brain teaser, as well as sociality.

Alzheimer's disease can start at a young age, there are about 10,000 working-age memory disorders in Finland.

In recent years, knowledge and the development of new drugs have increased tremendously - there is even talk of a vaccine of the future!

- It is a revolutionary idea that a progressive, degenerative brain disease could be treated with a vaccine.

The idea behind it is that the body begins to form an antibody against beta-amyloid, Rinne illuminates.

When there is too much beta-amyloid in the brain, it accumulates as an amyloid plaque and is one of the causes of memory disease.

Medications to relieve symptoms are already available.

Treatment should be started as early as possible, as soon as symptoms indicate memory impairment.

Juha Rinne talks about memory disease research. Photo: AlfaTV

- I also have patients who, even after 6-7 years of starting the current medication, are in good condition and completely independent in their daily activities, Rinne says.

- I believe that effective and safe medication will come into practice in 20 years.

Medicines will be given to people at a very asymptomatic stage if, for example, they have a hereditary predisposition to Alzheimer's, Rinne says.

Further research is still needed and is being done all the time.

So today we are at a good stage and hopeful about the future compared to 30-40 years ago.

For example, in the 1980s, no palliative medication was available for Alzheimer’s disease, and the diagnosis was made at a much later stage in the disease than it is today.

Direct speech on health, Thursday 3.12.

AlfaTV at 5 p.m.